Tonix Pharmaceuticals Holding Corp.
(NASDAQ : TNXP)

( )
TNXP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corp. Plc
1.28%20.521.7%$278.90m
MDCOThe Medicines Co.
-1.18%69.7620.2%$168.39m
VRXValeant Pharmaceuticals International, Inc.
0.07%27.7514.1%$163.28m
BHCBausch Health Cos., Inc.
0.07%27.750.0%$112.98m
GWPHGW Pharmaceuticals Plc
0.15%99.366.2%$88.17m
JAZZJazz Pharmaceuticals Plc
1.41%142.632.3%$73.22m
SAGESAGE Therapeutics, Inc.
0.17%151.788.6%$57.27m
PRGOPerrigo Co. Plc
-0.14%48.626.8%$55.84m
UTHRUnited Therapeutics Corp.
-1.51%93.4014.3%$43.16m
ICPTIntercept Pharmaceuticals, Inc.
1.51%87.9016.9%$42.69m
HZNPHorizon Therapeutics Plc
-0.86%31.006.6%$41.06m
ICLRICON plc
-0.79%155.154.2%$39.09m
ENDPEndo International Plc
-2.57%4.558.8%$34.21m
CTLTCatalent, Inc.
-0.12%51.542.4%$33.45m
AXSMAxsome Therapeutics, Inc.
4.31%34.122.0%$28.84m

Company Profile

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing small molecules and biologics to treat psychiatric, pain and addiction conditions, to improve biodefense through potential medical counter-measures, to treat transplant rejection and to treat gastric and pancreatic cancers. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and Tonmya. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in New York, NY.